Literature DB >> 11362125

Issues for women with heterosexually transmitted HIV disease.

S Gaskins1.   

Abstract

The encouraging outcome of new antiretroviral therapies has not been accompanied by a decrease in the incidence of HIV disease. There are reports of increases in AIDS in select geographical areas, minorities, and women. In 1997, 39% of cases in women were from heterosexual contact, whereas in men 7% of cases were from heterosexual contact. It is the most common mode of transmission in women globally and the only category of transmission in which the incidence of opportunistic infection has increased in the United States. Female anatomy, physiology, and sexual practices contribute to increasing risk of transmission, although there are no major biomedical differences in development of the disease related to gender. Two case examples illustrate the vulnerabilities, life-settings, pressures, and methods of coping for this population. Extensive discussion and review of the literature on the epidemiology, testing, disclosure, health care services, and prevention of transmission in women bring into focus strategies for improved education, diagnosis, care, and treatment.

Entities:  

Mesh:

Year:  1999        PMID: 11362125     DOI: 10.1089/apc.1999.13.89

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  2 in total

1.  Disparities in reported reasons for not initiating or stopping antiretroviral treatment among a diverse sample of persons living with HIV.

Authors:  Mallory O Johnson; Margaret A Chesney; Torsten B Neilands; Samantha E Dilworth; Robert H Remien; Lance S Weinhardt; F Lennie Wong; Stephen F Morin
Journal:  J Gen Intern Med       Date:  2008-11-18       Impact factor: 5.128

Review 2.  A scoping review and thematic analysis of social and behavioural research among HIV-serodiscordant couples in high-income settings.

Authors:  Joshua B Mendelsohn; Liviana Calzavara; Amrita Daftary; Sanjana Mitra; Joel Pidutti; Dan Allman; Adam Bourne; Mona Loutfy; Ted Myers
Journal:  BMC Public Health       Date:  2015-03-13       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.